Biggest coronavirus vaccine deal yet: $2.1 billion to Sanofi/GSK for up to 100 million doses
The United States will pay Sanofi and GlaxoSmithKline up to $2.1 billion to test and produce 100 million doses of an experimental coronavirus vaccine.
Biggest coronavirus vaccine deal yet: $2.1 billion to Sanofi/GSK for up to 100 million doses
USATODAY.com
0 shares
1 views
You might like
Related news coverage
Sanofi and GlaxoSmithKline Snag a $2.1 Billion Contract for Their Coronavirus Vaccine
Motley Fool
The U.S. government is supporting development and manufacturing of the coronavirus vaccine in exchange for 100 million doses.
-
US sinks another $2.1 billion into a potential vaccine
SeattlePI.com
-
Coronavirus: EU says it struck deal with Sanofi for 300 million doses of potential COVID-19 vaccine
euronews
-
Sanofi, GlaxoSmithKline in $2.1 billion vaccine deal with U.S.
CBS News
-
GlaxoSmithKline, Sanofi get $2.1B to fund Covid-19 vaccine under Operation Warp Speed
bizjournals
Advertisement
More coverage
Is Coronavirus Vaccine Made From Fetal Cell Lines?
Eurasia Review
By Matt Hadro
As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the..
The bright spot in Trump's coronavirus response
Business Insider